Evernow logo

Evernow Review

GLP-1 weight-loss telehealth · Independently scored 7.4/10

Best for: Women wanting insurance-covered branded GLP-1 weight loss alongside menopause and HRT care

7.4
★★★3.7/5

Evernow is a solid telehealth option with balanced features and pricing.

Evernow is a women's-focused, menopause-centered telehealth platform that prescribes branded GLP-1 weight loss medications including Ozempic, Wegovy, Zepbound, and Mounjaro via US-licensed clinicians. It is now accepting insurance for video visits, listing Blue Cross Blue Shield, Anthem, United Healthcare, and Aetna, and positions GLP-1 care as complementary to HRT. Membership starts around $35/month for menopause access, with 24/7 clinician messaging and one-time or membership care. Weight loss is one vertical alongside menopause and HRT care; medication cost depends on insurance.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Branded Ozempic and WegovyBranded Zepbound and MounjaroAccepts insuranceMenopause and HRT focus24/7 clinician messagingOne-time or membership careWomen's health focusCombines GLP-1 with HRT

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Evernow

7.3/ 10
Verified partner

Sunlight

Best for: compounded GLP-1 with unlimited telehealth visits and free shipping

★★★3.7/5

Editorial score · methodology

$159/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Sunlight review →
7.4/ 10
Verified partner

MadeMed

Best for: compounded GLP-1 in both injection and oral forms

★★★3.7/5

Editorial score · methodology

$219/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full MadeMed review →
8.3/ 10
Verified partner

Found

Best for: mainstream telehealth GLP-1 access

★★★★4.2/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideOrforglipron (foundayo)Semaglutide (wegovy)Tirzepatide (zepbound)Semaglutide (ozempic)Tirzepatide (mounjaro)
Get StartedRead full Found review →
Evernow logo
3.7 / 5
Our editorial rating
Visit Evernow

Evernow at a glance

Type
GLP-1 telehealth provider
Medications
Branded Ozempic and Wegovy, Branded Zepbound and Mounjaro
FDA status
No FDA warning letter on record

How we scored Evernow

Each dimension is scored algorithmically from Evernow’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.5/10

Evernow does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.

Effectiveness25%

8.5/10

Evernow offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

8.0/10

Online intake and platform experience — ongoing clinician messaging; 8 platform features disclosed.

Trust & Safety15%

7.4/10

Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).

Accessibility10%

6.8/10

Evernow's exact state footprint isn't published — confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.

Support10%

6.8/10

Clinician messaging between visits.

6scored dimensions
532providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Evernow review

Last checked July 2026
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What to expect when you sign up with Evernow

We walked Evernow’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Take an online quiz or click 'Get care' to begin at care.evernow.com/start.
  2. 2Choose a one-time insurance-eligible virtual visit or an ongoing membership with clinician messaging.
  3. 3Meet with a clinician who can prescribe GLP-1 medications (Ozempic, Wegovy, Zepbound, Mounjaro).
  4. 4Continue care via messaging and optional follow-up virtual visits.
Price shown before you start
  • Membership is advertised 'at $35/month' before intake, but no GLP-1 medication price is shown.
  • Primarily a menopause-care platform; weight loss / GLP-1 is one of several treatment areas.
  • Offers both a no-membership one-time visit and a subscription membership path.
  • No refund/cancellation policy, shipping details, or support phone/email observed on the pages reviewed.

GLP-1 medications Evernow offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

What we like

  • Prescribes FDA-approved branded GLP-1s, not compounded
  • Accepts insurance for video visits (BCBS, Anthem, UnitedHealthcare, Aetna)
  • Integrates GLP-1 weight loss with menopause and HRT care
  • Flexible one-time visit or low-cost membership models

Watch-outs

  • Weight loss is one vertical alongside menopause and HRT care
  • GLP-1 medication cost depends on insurance and is not posted
  • State availability not specified on the site

Evernow: a women's menopause clinic that also does branded GLP-1s

Evernow is not really a weight-loss startup that happens to treat women. It's the other way around: a women's-health telehealth platform built around menopause and hormone replacement therapy (HRT), with GLP-1 weight loss bolted on as one more symptom vertical. That framing matters, because it changes who this is genuinely a good fit for. If you're a woman in or near menopause who wants weight management handled by the same clinician thinking about your hot flashes, sleep, and hormones, Evernow is one of the few places that treats those as a single conversation. If you just want the cheapest fast track to a GLP-1, this isn't it.

Branded only — Ozempic, Wegovy, Zepbound, Mounjaro, no compounding

This is Evernow's clearest differentiator from the flood of compounding-pharmacy telehealth brands. Evernow prescribes FDA-approved, brand-name medication: semaglutide as Ozempic and Wegovy, and tirzepatide as Zepbound and Mounjaro. There are no compounded versions on the menu and no compounding-pharmacy partners on file. You're getting the same molecules, made by Novo Nordisk and Eli Lilly, that a doctor's office would write. For a lot of women that's the whole point — branded medication carries fewer of the sourcing and quality questions that hang over compounded GLP-1s.

How the money actually works (and why there's no sticker price)

Evernow's pricing is deliberately two separate things, and it's worth understanding the split before you sign up. The membership covers care access — unlimited clinician messaging, prescriptions, and a personalized plan — and it starts at roughly the mid-thirties per month for menopause access. That fee is for the relationship with the clinic, not for the drug.

The medication itself is a different bill entirely, and this is where Evernow diverges from cash-pay competitors. The company is now accepting insurance for video visits, listing Blue Cross Blue Shield, Anthem, UnitedHealthcare, and Aetna. So the cost of your Ozempic or Zepbound depends on your plan's coverage and your pharmacy copay — it could be a manageable copay if your insurer covers GLP-1s, or it could be the brand's full list price (well over a thousand dollars a month) if they don't. Evernow does not post a flat cash medication price, which is honest but means you can't price-shop it the way you can a compounded provider charging a fixed monthly rate. For context, the typical monthly cost across the providers we track sits around $170, but that number doesn't really apply to an insurance-routed model like this one.

What you should confirm before paying

  • Whether your specific insurance plan covers branded GLP-1s for weight loss — coverage varies wildly even within BCBS or Aetna
  • Your expected pharmacy copay, since that, not the membership fee, is the real cost driver
  • Whether Evernow operates in your state — the company does not publish a state-availability list, so check before you commit

The real reason to choose Evernow: GLP-1 and HRT under one roof

The genuine standout here is integration. Weight gain, metabolic change, and appetite shifts often arrive at the same life stage as perimenopause and menopause, and most weight-loss telehealth platforms treat the GLP-1 in isolation. Evernow positions GLP-1 care as complementary to HRT, with the same clinicians and 24/7 messaging covering both. For a woman who is already managing menopause symptoms and wants the weight-loss medication coordinated against her hormone therapy rather than prescribed by a separate, unaware service, that coordinated model is hard to find elsewhere. You can do a one-time visit or the ongoing membership, so you're not forced into a subscription to get started.

Who should skip it

Be honest with yourself about fit. Skip Evernow if you're a man, or a woman who isn't dealing with menopause or hormone questions — you'd be paying for a menopause-built platform to handle a single weight-loss need, and a dedicated GLP-1 provider will be more direct. Skip it if you have no GLP-1 insurance coverage and want a predictable cash price, because the insurance-dependent model leaves your medication cost unknowable up front. And skip it if you need to confirm same-day that it serves your state, since that information isn't published.

Trust and medical oversight

On the safety dimensions that matter most, Evernow looks solid. Prescriptions come from US-licensed clinicians, the medications are FDA-approved branded products rather than compounded formulations, and there are no FDA warning letters or enforcement actions on file for the company. Routing through insurance and real pharmacies adds another layer of conventional oversight. The honest caveats are about transparency, not safety: no posted medication price and no published state list. Those are inconvenience and homework items, not red flags. You can see how we weigh branded sourcing, oversight, and disclosure in our scoring methodology.

Bottom line

Evernow is a strong, narrow recommendation. For women who want FDA-approved branded GLP-1 weight loss managed alongside menopause and HRT care — ideally with insurance coverage to absorb the medication cost — it's one of the more thoughtful options out there, and the branded-only, insurance-accepting approach is a real advantage over compounding-first competitors. For everyone else, the menopause-centric design and unposted, insurance-dependent pricing make it the wrong tool. Know which of those you are before you book, confirm your coverage and your state, and it can be an excellent fit.

If you're weighing alternatives, Sesame Care ($59/month) and bmiMD ($99/month) are among the closest options we track to Evernow.

The Bottom Line

Evernow is a solid telehealth option with balanced features and pricing.

Score: 7.4/10Best for: Women wanting insurance-covered branded GLP-1 weight loss alongside menopause and HRT care

Ready to start with Evernow?

See current pricing and start your free consultation.

Evernow might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If you want built-in coaching and behavior-change support, consider Found.

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Evernow review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.

See Evernow's current pricing

Start your free consultation to check eligibility and today's price.